Fibrocell Science Inc. (OTC: FCSC)
March 3rd, 2011 we released our published research article, "TooNiceStocks Initiates Coverage on Fibrocell Science Inc. (OTC: FCSC) Pending June 22, 2011 FDA Decision with Elevated Interest". FCSC consolidated and dipped to $.73 and shares rallied as high as $1.78 on FDA approval or up to 140%. After our research article came out, research analysts at Rodman and Renshaw just set an "outperform" rating and a $3.00 price target on FCSC! Wow a big investment bank following TooNiceStocks, amazing! Read our original report here!


